Instrument Inactif

Autres langues Gyroscope Therapeutics Holdings plc

Actions

Gyroscope Therapeutics Holdings plc Reports Earnings Results for the Full Year Ended December 31, 2021	23/06/22
Novartis AG acquired Gyroscope Therapeutics Holdings plc on February 18, 2022	18/02/22
Syncona Shares Rise After Novartis Agrees to Buy Portfolio Company	22/12/21
Novartis to Acquire Gyroscope Therapeutics for Up to $1.5 Billion	22/12/21
Novartis AG signed an agreement to acquire Gyroscope Therapeutics Holdings plc for £1.1 billion.	22/12/21
Syncona Says Sanofi to Invest up to $60 Million in Gyroscope Therapeutics	08/11/21
Gyroscope Therapeutics Holdings plc announced that it expects to receive £44.5 million in funding from Sanofi Ventures	08/11/21
Gyroscope Therapeutics Holdings plc Announces Presentation of Positive Interim Phase I/II Data for Investigational Gene Therapy GT005 at Retina Society Annual Scientific Meeting	30/09/21
Gyroscope Therapeutics Announces Research Collaboration Agreement with Children’s Medical Research Institute to Develop Novel Gene Therapy Capsids	22/06/21
Gyroscope Therapeutics Holdings plc has withdrawn its IPO in the amount of $148.5 million.	07/05/21
Gyroscope Therapeutics Holdings plc has filed an IPO in the amount of $100 million.	16/04/21
Gyroscope Therapeutics Holdings Limited Auditor Raises 'Going Concern' Doubt	11/01/21
Gyroscope Therapeutics Limited acquired Orbit Biomedical Inc. from Syncona Portfolio Ltd and other shareholders.	11/04/19

Aucun résultat pour cette recherche